Tallacchini Mariachiara
Facoltà di economia e giurisprudenza, Università Cattolica Sacro Cuore, Piacenza.
Epidemiol Prev. 2017 Jan-Feb;41(1):14-19. doi: 10.19191/EP17.1.P014.007.
"Nudge, or nudging, refers to a policy approach inspired by behavioral sciences: it promotes the conducts identified as desirable by regulators without applying prohibition and coercion. This approach has gained a lot of momentum in the domain of health policies. Policy strategies based on behavioral insights appear ideal as to implementing healthier life styles and public health programs while minimizing compliance costs: from organ donation to food choices, from fighting obesity and chronic diseases to screening policies. Nudging, however, is not exempt from problems, especially in the sector of health, where individual free and informed consent constitutes a founding principle. Cancer screening programs, and especially breast cancer population tests, represent an interesting example for nudging strategies which have been widely applied but have also raised serious criticisms. Despite having been widely adopted by health systems, from the United States to the European Union, breast cancer screening programs keep raising debates about their actual impact on reducing mortality, risks of overdiagnosing and unnecessary or harmful treatments. In challenging the validity of screening programs, these controversies also affect their efficacy. Nudging has therefore been seen as a potentially useful tool in increasing participation, even though the extent of its actual impact remains ambiguous and problematic. For nudging to represent a relevant, powerful policy instrument its legitimacy requirements need to be identified. These concern the "right place" of behavioral-based measures within the traditional regulatory framework. The "right place" of nudging in science-based policies is part of a broader rethinking of what is democracy in "knowledge-based societies", namely through which procedures democratic institutions validate and legitimize their normative choices depending on uncertain and controversial knowledge."
助推,或称为推动,指的是一种受行为科学启发的政策方法:它在不实施禁止和强制手段的情况下,促进监管机构认定为可取的行为。这种方法在卫生政策领域已获得了很大的发展势头。基于行为洞察的政策策略在实施更健康的生活方式和公共卫生项目,同时将合规成本降至最低方面似乎很理想:从器官捐赠到食物选择,从对抗肥胖和慢性病到筛查政策。然而,助推并非没有问题,尤其是在卫生领域,个人自由和知情同意是一项基本原则。癌症筛查项目,尤其是乳腺癌群体检测,是助推策略的一个有趣例子,这些策略已被广泛应用,但也引发了严重批评。尽管从美国到欧盟的卫生系统都广泛采用了乳腺癌筛查项目,但关于其对降低死亡率、过度诊断风险以及不必要或有害治疗的实际影响,一直存在争议。在质疑筛查项目的有效性时,这些争议也影响了其效果。因此,助推被视为提高参与度的一种潜在有用工具,尽管其实际影响程度仍不明确且存在问题。为了使助推成为一种相关的、有力的政策工具,需要确定其合法性要求。这些要求涉及基于行为的措施在传统监管框架内的“正确位置”。助推在基于科学的政策中的“正确位置”是对“知识社会”中民主是什么进行更广泛反思的一部分——即民主机构通过哪些程序根据不确定和有争议的知识来验证和使其规范性选择合法化。